Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy-Reference-Cited by-同舟云学术

Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy

Published:2012-03 Issue:2 Volume:21 Page:110-117
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Chen Zhuo-jia,Wang Xue-ding,Wang Hong-sheng,Chen Shu-da,Zhou Lie-min,Li Jia-li,Shu Wen-ying,Zhou Jue-qian,Fang Zi-yan,Zhang Yu,Huang Min

Funder

Science and Technology Ministry of China

National Natural Science Foundations of China

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference35 articles.

1. Oral valproic acid for epilepsy – long-term experience in therapy and side effects;Gerstner;Expert Opin Pharmacother,2008

2. Gas chromatographic measurement of plasma levels of sodium valproate: tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics;Vajda;Clin Exp Pharmacol Physiol,1978

3. Sodium valproate: monotherapy and polytherapy;Covanis;Epilepsia,1982

4. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience;Perucca;CNS Drugs,2002

5. Valproic acid hepatic fatalities: a retrospective review;Dreifuss;Neurology,1987

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An ID-HPLC–MS/MS based candidate reference measurement procedure for the quantification of valproic acid in human serum;Accreditation and Quality Assurance;2024-09-13

2. Association of Valproic Acid and Its Main Metabolites’ Plasma Concentrations with Clinical Outcomes among Epilepsy Patients: A 10-Year Retrospective Study Based on Therapeutic Drug Monitoring;Drug Metabolism and Disposition;2024-01-09

3. Successful LC-MS/MS assay development and validation for determination of valproic acid and its metabolites supporting proactive pharmacovigilance;Journal of Pharmaceutical and Biomedical Analysis;2023-09

4. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises;Pharmacology & Therapeutics;2022-12

5. Greenness assessment profile of a QbD screen-printed sensor for real-time monitoring of sodium valproate;Microchemical Journal;2022-11